A

Acotec Scientific Holdings
6669

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$2.38B
EV
HK$1.68B
Shares Outstanding
313.39M
Beta
0.27

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$12.17
P/E 2025E
19.34x
P/Revenue 2025E
3.06x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Acotec Scientific Holdings Limited

gainify

A

Acotec Scientific Holdings Limited

6669

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China, Europe, and internationally. The company’s products include AcoArt Orchid & Dhalia, a paclitaxel DCB used ...

Sector

Healthcare

Industry

Medical - Devices

CEO

Li, Jing

Employees

650

IPO Date

2021-08-24

Headquarters

Building No. 1, 4-5th Floor, 16 North Hongda Road, Beijing Economic-Technological Dev. Area, Beijing China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.